Most Read Articles
Roshini Claire Anthony, 11 Sep 2019

Beta-blockers could reduce mortality risk in patients with heart failure with reduced ejection fraction (HFrEF) and moderate or moderately-severe renal dysfunction without causing harm, according to the BB-META-HF* trial presented at ESC 2019.

Prof. Vincent Wong, Prof. Ray Kim, Dr. Tan Poh Seng, 10 Sep 2019
Chronic hepatitis B (CHB) remains a major public health concern because of its worldwide distribution and potential adverse sequelae, including cirrhosis and hepatocellular carcinoma (HCC). At a recent symposium held during the GIHep Singapore 2019, Professor Vincent Wong from the Chinese University of Hong Kong and Professor Ray Kim from the Stanford University School of Medicine, Stanford, California, US, discussed antiviral treatments for CHB, with a focus on the novel agent tenofovir alafenamide (Vemlidy®). Dr Tan Poh Seng from the National University Hospital, Singapore, chaired the symposium.
11 Sep 2019
Blood pressure (BP) in children is influenced by early-life exposure to several chemicals, built environment and meteorological factors, suggests a study.
Pearl Toh, Yesterday
The use of SGLT-2* inhibitors was not associated with a higher risk of severe or nonsevere urinary tract infections (UTIs) in patients with type 2 diabetes (T2D) compared with DPP**-4 inhibitors or GLP-1*** receptor agonists, a population-based cohort study shows.

Men with depression, low fertility-related QOL more likely to have erectile dysfunction

03 Aug 2019

Lower fertility-related quality of life (QOL) and depression show a robust association with erectile dysfunction in men of couples with unexplained infertility, but neither of these is associated with spermatogenesis or testosterone levels, according to a study.

This secondary analysis of a large, multicentre, randomized controlled trial in couples with unexplained fertility included 708 men (mean age, 34.2 years), who underwent baseline semen analysis with measurement of fasting total testosterone and gonadotropin. Participants also completed surveys, including the Fertility Quality of Life (FertiQOL), the Patient Health Questionnaire-9 (PHQ-9) and the International Index of Erectile Function (IIEF).

Total testosterone, with low total testosterone defined as <264 ng/dl, semen parameters and the IIEF score were the primary outcomes. Multivariable logistic regression analyses were performed, adjusting for age, race, body mass index, education, smoking, alcohol use, infertility duration and comorbidity.

Fifty-nine men (8.3 percent) had a PHQ-9 score of 5, which was consistent with depression, while 99 (14.0 percent) had low total cholesterol, and 63 (9.0 percent) had mild or worse erectile dysfunction.

The FertiQOL score and depression did not show any association with total cholesterol or any semen parameter, but the FertiQOL score inversely correlated with erectile dysfunction (for every 5-point score decline; adjusted odds ratio [aOR], 1.30, 95 percent CI, 1.16–1.46).

Furthermore, erectile dysfunction was significantly more likely to manifest in men with vs without depression (aOR, 6.31, 3.12–12.77).

“Erectile dysfunction in infertile men merits longitudinal investigation in future studies,” the investigators said.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Roshini Claire Anthony, 11 Sep 2019

Beta-blockers could reduce mortality risk in patients with heart failure with reduced ejection fraction (HFrEF) and moderate or moderately-severe renal dysfunction without causing harm, according to the BB-META-HF* trial presented at ESC 2019.

Prof. Vincent Wong, Prof. Ray Kim, Dr. Tan Poh Seng, 10 Sep 2019
Chronic hepatitis B (CHB) remains a major public health concern because of its worldwide distribution and potential adverse sequelae, including cirrhosis and hepatocellular carcinoma (HCC). At a recent symposium held during the GIHep Singapore 2019, Professor Vincent Wong from the Chinese University of Hong Kong and Professor Ray Kim from the Stanford University School of Medicine, Stanford, California, US, discussed antiviral treatments for CHB, with a focus on the novel agent tenofovir alafenamide (Vemlidy®). Dr Tan Poh Seng from the National University Hospital, Singapore, chaired the symposium.
11 Sep 2019
Blood pressure (BP) in children is influenced by early-life exposure to several chemicals, built environment and meteorological factors, suggests a study.
Pearl Toh, Yesterday
The use of SGLT-2* inhibitors was not associated with a higher risk of severe or nonsevere urinary tract infections (UTIs) in patients with type 2 diabetes (T2D) compared with DPP**-4 inhibitors or GLP-1*** receptor agonists, a population-based cohort study shows.